T2Candida® to guide antifungal and lengh of treatment of candidemia in a pediatric multivisceral transplant recipient.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/35900

Title:	T2Candida® to guide antifungal and lengh of treatment of candidemia in a pediatric multivisceral transplant recipient.
Authors:	Falces-Romero, Iker Cendejas-Bueno, Emilio Laplaza-González, María Escosa-García, Luis Schuffelmann-Gutiérrez, Cristina Calderón-Llopis, Belén Pemán, Javier de la Oliva, Pedro García-Rodríguez, Julio View more
Keywords:	Candidemia Multivisceral transplant recipient T2Candida View more
Issue Date:	Sep-2018
Citation:	Med Mycol Case Rep.2018 Sep;(21):66-68
Abstract:	A case of 1-year- old male multivisceral transplant recipient with candidemia diagnosed by the T2Candida® test is presented. Optimal management of the candidemia complemented the treatment of the global clinical episode. Duration of treatment might be established much more precisely with the T2Candida® test than with blood cultures.
PMID:	30094130
URI:	https://hdl.handle.net/20.500.12530/35900
Rights:	openAccess
ISSN:	2211-7539
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos Hospitales > H. U. La Paz > Artículos

Files in This Item:

File	Description	Size	Format
PMC6076387.pdf		330.06 kB	Adobe PDF	View/Open